Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07418450

Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?

During EBUS staging in patients with mediastinal lymphadenopathy, it is planned to perform a first round of staging with change of the needle between all lymph nodes and a second round of staging without change of the needle.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Lung Cancer (Diagnosis) Disease Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Pathologic Processes Pathological Conditions, Signs and Symptoms Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pulmonary lesion suspicious for lung cancer or histologically confirmed lung cancer
  • indication for mediastinal staging

Exclusion criteria

-

Treatment and study plan

EBUS-TBNA

Diagnostic Test

During EBUS staging, the needle well be changed between all lymph node stations in a first round. The EBUS staging will be repeated without the change of the needle between the lymph node stations.

Primary outcomes

  1. Agreement between the two rounds of EBUS staging

    Time frame: 18 months

Study contacts

Contact information is provided by the study sponsor or research team.

Daniela Gompelmann

CONTACT

[email protected]

0043 1 40400 47730

Sponsors and collaborators

Lead sponsor

University of Vienna

Other

Registry information

Official study title

Discrimination of N2a and N2b by EBUS-TBNA: is a Needle Change Necessary? - a Prospective Pilot Study

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Feb 18, 2026
Registry last updated
Feb 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.